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Abstract
Introduction: Congenital fibrinogen deficiency is a rare coagulation disorder usually responsible for hemorrhagic
diathesis. However, it can be associated with thrombosis and there have been limited reports of arterial thrombotic
complications in these patients.
Case presentation: A 42-year-old Tunisian man with congenital hypofibrinogenemia and no cardiovascular risk
factors presented with new onset prolonged angina pectoris. An electrocardiogram showed features of inferior
acute myocardial infarction. His troponin levels had reached 17 ng/L. Laboratory findings confirmed
hypofibrinogenemia and ruled out thrombophilia. Echocardiography was not useful in providing diagnostic
elements but did show preserved left ventricular function. Coronary angiography was not performed and our
patient did not receive any anticoagulant treatment due to the major risk of bleeding. Magnetic resonance
imaging confirmed myocardial necrosis. Our patient was managed with aspirin, a beta-blocker, an angiotensin-
converting enzyme inhibitor and statin medication. The treatment was well tolerated and no ischemic recurrence
was detected.
Conclusion: Although coronary thrombosis is a rare event in patients with fibrinogen deficiency, this condition is
of major interest in view of the difficulties observed in managing these patients.
Introduction
Hypo- and afibrinogenemia are rare congenital coagula-
tion disorders with an estimated incidence of one in
500,000 births [1]. They are usually responsible for an
increased bleeding tendency. Although uncommon,
some cases of venous and arterial thrombotic events
associated with fibrinogen deficiency have been reported
in the literature [1-9]. The mechanism of this apparently
paradoxical thrombotic tendency, which has long
remained problematic, has now been partially clarified
[10].
Case presentation
We report the case of a 42-year-old Tunisian man, born
out of a consanguineous marriage, who had no cardio-
vascular risk factors and was followed-up for hypofibri-
nogenemia diagnosed three years previously due to
bleeding after dental care. He had no known family his-
tory of fibrinogen deficiency. He was admitted for an
acute typical anginal pain which occurred at rest and
continued for several hours.
On physical examination he had no fever, his blood
pressure was 120/70 mmHg, his heart rate was 65 beats
per minute and cardiopulmonary auscultation was nor-
mal. An electrocardiogram (ECG) on admission, seven
hours after the onset of pain (Figure 1A) showed an ele-
vation of the ST segment in inferior leads and an ST-
segment depression in DI, aVL. His troponin I and crea-
tine phosphokinase levels were elevated to 17 ng/L and
820IU/L respectively. There was no sign of inflamma-
tion; his C-reactive protein level was 5 mg/L and white
blood cell count, 7000 cells/mL. Bleeding-related tests
were carried out. His fibrinogen level was 0.3 g/L using
the Von Clauss method, and < 0.16 g/L using the
immunological method. His activated partial thrombo-
plastin time was > 120 seconds (control: 32 seconds),
prothombin activity < 10% and thrombin time > 120
seconds (control: 13 seconds). His platelet count
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3) and bleeding time (140 seconds) were
normal. A transthoracic echocardiography estimated his
left ventricular ejection fraction at 61% without evidence
of segmental motion abnormalities. A coronary
angiography was not performed in view of the major
risk of bleeding. Cardiac magnetic resonance imaging
(MRI) on day 5 (Figure 2) showed the presence of
almost complete transmural enhancement of the
Figure 1 ECG findings. (A) Electrocardiogram on admission. ST-segment elevation in DIII, aVF and ST- segment depression in DI, aVL. (B)
Electrocardiogram on the seventh day. Q wave in inferior leads and apicolateral subepicardial ischemia.
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investigation for acute myocardial infarction in a young
adult was otherwise negative; our patient did not have
a n yp r o t e i nCo rp r o t e i nSo ra na n t i t h r o m b i nd e f i -
ciency; there was neither a Factor V Leiden nor pro-
thrombin G20210 mutation, no anti-phospholipid
antibodies (lupus type v inhibitor, anticardiolipin or
anti-2-glycoprotein-1 antibodies) were detected and his
plasma homocysteine level was normal. His fasting glu-
cose (0.9 g/L) and hemoglobin A1C (4.7%) levels, lipid
profile (cholesterol: 1.8 g/L; high density cholesterol:
0.47 g/L; triglycerides: 1.6 g/L; low density cholesterol
(Friedewald formula): 1.0 g/L) and liver function tests
were also normal. Transesophageal echocardiography
ruled out an emboligenic disease. Our patient was man-
aged with aspirin, atenolol, captopril and atorvastatin
but did not receive any anticoagulant treatment. He did
not experience any angina recurrence.
A submaximal exercise test on the sixth day was nega-
tive. An electrocardiogram on the seventh day (Figure
1B) showed a Q wave in inferior leads with apicolateral
subepicardial ischemia. We did not detect any recur-
rence of the myocardial ischemia. A cardiac MRI per-
formed one month after the acute episode identified a
zone of myocardial necrosis and wall thinning, confirm-
ing the initial diagnosis (Figure 3).
Discussion
Afibrinogenemia and hypofibrinogenemia (in its isolated
type; not associated with dysfibrinogenemia) are conge-
nital quantitative abnormalities of fibrinogen. They
expose patients to a bleeding risk of variable severity
depending on their phenotype. Thrombotic complica-
tions, however, have been reported in the literature in
isolated cases. These cases were venous [1] or arterial
thromboses and most occurred after administration of
cryoprecipitates or fibrinogen. Nevertheless, some cases
of spontaneous arterial thrombotic events have been
reported (Table 1). The majority of them concerned
peripheral arteries in patients with afibrinogenemia
(where fibrinogen levels are lower than those in patients
with hypofibrinogenemia, leading to a more significant
rise in the circulating thrombin, but it muct be noted
that afibrinogenemia also has a greater prevalence). To
the best of our knowledge, only a single case of myocar-
dial infarction has previously been reported, in a 27-
year-old male patient with afibrinogenemia [2]. In our
patient, in addition to the typical clinical, ECG and bio-
logical features which were coherent with the definition
of acute myocardial infarction, the diagnosis was further
confirmed by MRI. Nevertheless, the coronary thrombo-
sis was not viewed by a coronary computed tomography
angiography (which was unavailable) or by invasive
explorations, which were problematic in view of the
hemorrhagic risk. For the patient described by Kumar et
al. [2], who was admitted two hours after pain onset, as
well as for our patient, who was admitted seven hours
after pain onset, the risk of bleeding that accompanies
coronary angioplasty (and its adjunctive anticoagulant
therapy) seemed to outweigh the expected benefit and it
was therefore not indicated in either case. Also, because
of the precarious balance of the process of hemostasis,
thrombolytics and anti-thrombotic treatments could not
be used. The use of these treatments classically contra-
indicated in fibrinogen deficient patients has neverthe-
less been described in cases of thrombotic
complications, often in parallel with fibrinogen infusion
[3-5,10].
The increased risk of thrombosis in cases of fibrinogen
deficiency could be explained by a rise in the level of
Figure 2 Contrast-enhanced inversion-recovery magnetic resonance study on (A) long axis and (B) short-axis images during the
subacute phase (day five). Almost complete transmural enhancement in the infero-apicolateral wall (arrowheads).
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fibrin (previously known as antithrombin I factor)
[3,10]. The thrombin, playing the role of platelet activa-
tor, favors the excretion of Von Willebrand factor from
platelet alpha-granules. This later enhances platelet
aggregation by binding to glycoprotein IIb/IIIa, leading
to the formation of loose large thrombi [3]. Concerning
the pathophysiologic mechanism, antiaggregant treat-
ments can be effective in preventing the genesis of
thrombotic events. Our patient received only aspirin;
the patient described by Kumar et al. [2] received dual
antiplatelet therapy (aspirin and clopidogrel). Neither of
these two patients had an ischemic recurrence or a
hemorrhagic complication.
Conclusion
Arterial thromboses are at present recognized as possi-
ble, even if rare, manifestations of fibrinogen deficien-
cies. In addition to the particularity of their pathology,
these thromboses raise diagnostic and therapeutic
Figure 3 Long-axis image on contrast-enhanced inversion-recovery magnetic resonance performed one month after the acute
episode. Wall thinning and transmural enhancement in the infero-apicolateral wall (arrowheads).
Table 1 Cases of arterial spontaneous thrombotic complications in patients with fibrinogen deficiency reported in the
literature
Reference Age
(years),
sex
Fibrinogen
deficiency
Thrombotic event
[6] 33 M Afibrinogenemia Iliac artery thrombosis and toe necrosis
[7] 37 F Afibrinogenemia Ischemic necrosis of the first left toe
[8] 37 F Afibrinogenemia Bilateral distal ischemia of fingers and toes
[1] 14 F Afibrinogenemia Ischemic necrosis of the right foot due to popliteal artery thrombosis
[3] 30 M Afibrinogenemia Ischemic lesions of the feet secondary to an occlusive lesion of the hypogastric artery and highly
stenotic lesions of the iliac arteries (two episodes at three-year interval). After surgical bypass,
asymptomatic occlusion of the bypass occurred at Day three.
[4] 22 M Afibrinogenemia Ischemic stroke in a context of aortic marastic endocarditis
[9] 21 F Afibrinogenemia Ischemia of the fifth toe then of the fourth toe
[2] 27 M Afibrinogenemia Inferior acute myocardial infarction
[5] 35 F Hypofibrinogenemia Renal infarction
60 F Hypofibrinogenemia Toe ischemia by bilateral thrombosis of the anterior tibial arteries
F: female; M: male.
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sis balance in these patients.
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